Charles Schwab’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.46M | Buy |
1,186,120
+96,671
| +9% | +$200K | ﹤0.01% | 2605 |
|
|
2025
Q1 | $2.4M | Sell |
1,089,449
-16,354
| -1% | -$36K | ﹤0.01% | 2556 |
|
|
2024
Q4 | $1.69M | Buy |
1,105,803
+9,418
| +0.9% | +$14.4K | ﹤0.01% | 2732 |
|
|
2024
Q3 | $2.18M | Sell |
1,096,385
-41,411
| -4% | -$82.4K | ﹤0.01% | 2684 |
|
|
2024
Q2 | $3.98M | Buy |
1,137,796
+46,658
| +4% | +$163K | ﹤0.01% | 2439 |
|
|
2024
Q1 | $3.02M | Buy |
1,091,138
+93,937
| +9% | +$260K | ﹤0.01% | 2472 |
|
|
2023
Q4 | $1.7M | Buy |
997,201
+14,192
| +1% | +$24.1K | ﹤0.01% | 2666 |
|
|
2023
Q3 | $1.01M | Buy |
983,009
+239,430
| +32% | +$247K | ﹤0.01% | 2793 |
|
|
2023
Q2 | $863K | Buy |
743,579
+12,453
| +2% | +$14.4K | ﹤0.01% | 2819 |
|
|
2023
Q1 | $1.1M | Sell |
731,126
-66,919
| -8% | -$101K | ﹤0.01% | 2702 |
|
|
2022
Q4 | $2M | Buy |
798,045
+57,039
| +8% | +$143K | ﹤0.01% | 2570 |
|
|
2022
Q3 | $3.13M | Buy |
741,006
+9,951
| +1% | +$42K | ﹤0.01% | 2448 |
|
|
2022
Q2 | $2.04M | Buy |
731,055
+15,749
| +2% | +$43.9K | ﹤0.01% | 2562 |
|
|
2022
Q1 | $4.09M | Buy |
715,306
+19,049
| +3% | +$109K | ﹤0.01% | 2374 |
|
|
2021
Q4 | $6.36M | Sell |
696,257
-269
| -0% | -$2.46K | ﹤0.01% | 2229 |
|
|
2021
Q3 | $7.45M | Buy |
696,526
+59,080
| +9% | +$632K | ﹤0.01% | 2177 |
|
|
2021
Q2 | $9.89M | Buy |
637,446
+67,835
| +12% | +$1.05M | ﹤0.01% | 2008 |
|
|
2021
Q1 | $9.23M | Buy |
569,611
+15,870
| +3% | +$257K | ﹤0.01% | 2003 |
|
|
2020
Q4 | $11.7M | Buy |
553,741
+10,657
| +2% | +$226K | ﹤0.01% | 1770 |
|
|
2020
Q3 | $8.05M | Buy |
543,084
+3,248
| +0.6% | +$48.1K | ﹤0.01% | 1828 |
|
|
2020
Q2 | $7.94M | Buy |
539,836
+41,376
| +8% | +$609K | ﹤0.01% | 1780 |
|
|
2020
Q1 | $5.85M | Buy |
498,460
+6,685
| +1% | +$78.5K | ﹤0.01% | 1753 |
|
|
2019
Q4 | $11.6M | Buy |
491,775
+65,162
| +15% | +$1.53M | 0.01% | 1594 |
|
|
2019
Q3 | $7.89M | Buy |
426,613
+8,875
| +2% | +$164K | ﹤0.01% | 1739 |
|
|
2019
Q2 | $7.77M | Buy |
417,738
+21,519
| +5% | +$400K | ﹤0.01% | 1748 |
|
|
2019
Q1 | $9.68M | Buy |
396,219
+14,714
| +4% | +$360K | 0.01% | 1614 |
|
|
2018
Q4 | $9.9M | Buy |
381,505
+2,460
| +0.6% | +$63.8K | 0.01% | 1463 |
|
|
2018
Q3 | $12M | Buy |
379,045
+50,064
| +15% | +$1.58M | 0.01% | 1509 |
|
|
2018
Q2 | $12.8M | Buy |
328,981
+58,965
| +22% | +$2.29M | 0.01% | 1424 |
|
|
2018
Q1 | $7.45M | Buy |
270,016
+27,082
| +11% | +$748K | 0.01% | 1699 |
|
|
2017
Q4 | $4.4M | Buy |
242,934
+81,735
| +51% | +$1.48M | ﹤0.01% | 1984 |
|
|
2017
Q3 | $2.6M | Sell |
161,199
-9,356
| -5% | -$151K | ﹤0.01% | 2191 |
|
|
2017
Q2 | $2.36M | Buy |
170,555
+1,026
| +0.6% | +$14.2K | ﹤0.01% | 2162 |
|
|
2017
Q1 | $2.54M | Buy |
169,529
+49,211
| +41% | +$738K | ﹤0.01% | 2117 |
|
|
2016
Q4 | $1.58M | Sell |
120,318
-5,950
| -5% | -$78K | ﹤0.01% | 2271 |
|
|
2016
Q3 | $2.18M | Buy |
126,268
+14,500
| +13% | +$250K | ﹤0.01% | 2088 |
|
|
2016
Q2 | $2.02M | Buy |
111,768
+8,772
| +9% | +$158K | ﹤0.01% | 2067 |
|
|
2016
Q1 | $1.96M | Buy |
102,996
+2,104
| +2% | +$40K | ﹤0.01% | 2058 |
|
|
2015
Q4 | $2.69M | Buy |
100,892
+12,776
| +14% | +$341K | ﹤0.01% | 1923 |
|
|
2015
Q3 | $2.15M | Buy |
88,116
+43,556
| +98% | +$1.06M | ﹤0.01% | 2026 |
|
|
2015
Q2 | $1.39M | Buy |
44,560
+3,610
| +9% | +$113K | ﹤0.01% | 2263 |
|
|
2015
Q1 | $596K | Buy |
40,950
+200
| +0.5% | +$2.91K | ﹤0.01% | 2568 |
|
|
2014
Q4 | $410K | Hold |
40,750
| – | – | ﹤0.01% | 2707 |
|
|
2014
Q3 | $340K | Buy |
40,750
+12,250
| +43% | +$102K | ﹤0.01% | 2737 |
|
|
2014
Q2 | $352K | Buy |
+28,500
| New | +$352K | ﹤0.01% | 2788 |
|